These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31900502)

  • 41. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
    Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V; Beltran-Aguilar VM; Arias-Peralta AG; De Avila-Gonzalez N; Guajardo-Jauregui N
    Clin Rheumatol; 2023 Oct; 42(10):2677-2690. PubMed ID: 36627529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.
    Karakontaki FV; Panselinas ES; Polychronopoulos VS; Tzioufas AG
    Autoimmun Rev; 2021 Feb; 20(2):102742. PubMed ID: 33333235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study.
    Lohse A; Bossert M; Bozgan AM; Charpentier A; Guillochon C; Bourgoin C; Balblanc JC; Conrozier T
    Clin Exp Rheumatol; 2020; 38(6):1273. PubMed ID: 33253100
    [No Abstract]   [Full Text] [Related]  

  • 46. Association of mastocytosis with inflammatory joint diseases: a series of 31 patients.
    Bader-Meunier B; Bulai Livideanu C; Larroche C; Durieu I; Artru L; Beucher A; Cormier G; Cornec D; Delarco M; Dubost JJ; Fontaine C; Gourin MP; Javier RM; de Jauréguiberry JP; Maisonneuve H; Toussirot E; Ugo V; Echaubard S; Mahlaoui N; Aouba A; Bodemer C; Briot K; Frenzel L; Lortholary O; Chandesris MO; Hermine O;
    Semin Arthritis Rheum; 2014 Dec; 44(3):362-5. PubMed ID: 25037281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melatonin supplementation improves rheumatological disease activity: A systematic review.
    de Carvalho JF; Skare TL
    Clin Nutr ESPEN; 2023 Jun; 55():414-419. PubMed ID: 37202076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rheumatic Conditions as Risk Factors for Self-Harm: A Retrospective Cohort Study.
    Prior JA; Paskins Z; Whittle R; Abdul-Sultan A; Chew-Graham CA; Muller S; Bajpai R; Shepherd TA; Sumathipala A; Mallen CD
    Arthritis Care Res (Hoboken); 2021 Jan; 73(1):130-137. PubMed ID: 32526099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence of severe fatigue in rheumatic diseases: an international study.
    Overman CL; Kool MB; Da Silva JA; Geenen R
    Clin Rheumatol; 2016 Feb; 35(2):409-15. PubMed ID: 26272057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutropenia in the Elderly: A Rheumatology Perspective.
    Yeoh SA; Fox C; Hull R
    Drugs Aging; 2016 Aug; 33(8):585-601. PubMed ID: 27402172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suicidal behaviors in patients with rheumatic diseases: a narrative review.
    Calandre EP; Rico-Villademoros F; Slim M
    Rheumatol Int; 2018 Apr; 38(4):537-548. PubMed ID: 29264638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cardiovascular disease in rheumatic diseases].
    Nasonov EL; Popkova TV; Novikova DS
    Ter Arkh; 2016; 88(5):4-12. PubMed ID: 27458622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of cardiovascular risk factors].
    Krüger K
    Z Rheumatol; 2016 Mar; 75(2):173-80; quiz 181-2. PubMed ID: 26924198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative Management of Rheumatic Disease and Therapies.
    Zisa D; Goodman SM
    Rheum Dis Clin North Am; 2022 May; 48(2):455-466. PubMed ID: 35400371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.
    Mitchell EL; Lau PKH; Khoo C; Liew D; Leung J; Liu B; Rischin A; Frauman AG; Kee D; Smith K; Brady B; Rischin D; Gibson A; Mileshkin L; Klein O; Weickhardt A; Arulananda S; Shackleton M; McArthur G; Östör A; Cebon J; Solomon B; Buchanan RR; Wicks IP; Lo S; Hicks RJ; Sandhu S
    Eur J Cancer; 2018 Dec; 105():88-102. PubMed ID: 30439628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
    Pablos JL; Abasolo L; Alvaro-Gracia JM; Blanco FJ; Blanco R; Castrejón I; Fernandez-Fernandez D; Fernandez-Gutierrez B; Galindo-Izquierdo M; Gonzalez-Gay MA; Manrique-Arija S; Mena Vázquez N; Mera Varela A; Retuerto M; Seijas-Lopez A;
    Ann Rheum Dis; 2020 Sep; 79(9):1170-1173. PubMed ID: 32532753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature.
    Harrold LR; Andrade SE
    Semin Arthritis Rheum; 2009 Apr; 38(5):396-402. PubMed ID: 18336875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adherence to EULAR's recommendations on comorbidity management minimizes the discontinuation of bDMARDS for intolerance in patients with chronic inflammatory rheumatic diseases.
    Reyes-Rivet L; Bellier A; Baillet A; Pham T; Gaudin P; Allenet B; Gastaldi R
    Joint Bone Spine; 2021 Dec; 88(6):105234. PubMed ID: 34098103
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
    Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA
    BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
    Aikawa NE; Twardowsky Ade O; Carvalho JF; Silva CA; Silva IL; Ribeiro AC; Saad CG; Moraes JC; Toledo RA; Bonfá E
    Clinics (Sao Paulo); 2011; 66(7):1171-5. PubMed ID: 21876969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.